TSHR and hematocrit: In another study by the same group, 6% of 700 patients with HT were found to have clinical evidence of thyroid-associated ophthalmopathy and TSHR-stimulating antibodies were present in 69% of these cases, in contrast to only 6% of HT patients without eye signs [43].